Amgen suffers another setback in antibody IP war
EPO invalidates PCSK9 patent ahead of crucial CAFC case to be heard next month
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.